Palvella Therapeutics, Inc.

Insider Reports History

Location
125 Strafford Ave, Suite 360, Wayne, PA
Signature
By: /s/ Kathleen A. McGowan For: Jeffrey S. Martini
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Palvella Therapeutics, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PIERIS PHARMACEUTICALS, INC. Chief Scientific Officer Non-Qualified Stock Option (right to buy) 124K Feb 5, 2025 Direct
PIERIS PHARMACEUTICALS, INC. Chief Scientific Officer Incentive Stock Option (right to buy) 5.37K Feb 5, 2025 Direct

Insider Reports Filed by Palvella Therapeutics, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PVLA PALVELLA THERAPEUTICS, INC. Feb 5, 2025 2 $0 4 Feb 7, 2025 Chief Scientific Officer
PVLA PALVELLA THERAPEUTICS, INC. Feb 5, 2025 2 $0 4 Feb 7, 2025 CFO and Treasurer
PVLA PALVELLA THERAPEUTICS, INC. Feb 5, 2025 1 $0 4 Feb 7, 2025 President and CEO, Director
PVLA PALVELLA THERAPEUTICS, INC. Feb 5, 2025 2 $0 4 Feb 7, 2025 Chief Operating Officer